Paul Peter Tak, Chief Executive Officer at Candel Therapeutics, sold CADL on Sep 11, 2026
Data as of Oct 16
▼ SELL$621K59,379 shares at $10.46Paul Peter Tak Chief Executive OfficerCADL Candel Therapeutics, Inc.
- Traded
- Sep 11, 2026
- Disclosed
- Sep 11, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
CADL since disclosure
−22.3%
after the sale
Similar stocks (XLV) since disclosure
+6.9%
XLV — its sector index fund
Change in closing price from Sep 11, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLPaul Peter Tak Chief Executive OfficerCADL Candel Therapeutics, Inc.$2.5Mdisclosed Sep 11 · filed 1 day after the trade